4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp
Fig 2
Histogram of bactericidal assay (SBA) titers using rabbit (rSBA) (a) and human (hSBA) (b) serum as source of complement against meningococcal strains expressing v1, v2 and v3 colored in blue, red and green respectively.